CNS Pharmaceuticals
CNSP
CNSP
5 hedge funds and large institutions have $351K invested in CNS Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
5
Holders Change
+5
Holders Change %
–
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EIM
1
Essex Investment Management
Boston,
Massachusetts
| $306K | 77,458 | +77,458 | New |
|
|
IAN
2
Integrated Advisors Network
Dallas,
Texas
| $42K | 10,700 | +10,700 | New |
|
3
BlackRock
New York
| $2K | 577 | +577 | New |
|
|
GI
4
Gradient Investments
Arden Hills,
Minnesota
| $1K | 200 | +200 | New |
|
|
CFGS
5
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
6
Morgan Stanley
New York
| $0 | 53 | +53 | New |
|